ALOXI 0.25MG/5ML VIAL FOR I.V

*IT IS A SEROTONIN-3 (5-HT3) RECEPTOR ANTAGONIST INDICATED IN ADULTS FOR (MODERATELY TO HIGHLY) EMETOGENIC CANCER CHEMOTHERAPY AND PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING (PONV) FOR UP TO 24 HOURS FOLLOWING SURGERY. *IT IS ALSO INDICATED IN PEDIATRIC PATIENTS AGED 1 MONTH TO LESS THAN 17 YEARS FOR PREVENTION OF ACUTE NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF EMETOGENIC CANCER CHEMOTHERAPY INCLUDING HIGHLY EMETOGENIC CANCER CHEMOTHERAPY.